Labcorp Holdings Inc - Company Profile
Powered by 
All the sales intelligence you need on Labcorp Holdings Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Labcorp Holdings Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Labcorp Holdings Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Labcorp Holdings Inc (Labcorp), formerly Laboratory Corporation of America Holdings, is a life sciences and healthcare company. It offers blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin AI C, health and wellness services, lead optimization, analytical services, chemistry manufacturing services, early phase development solutions, crop protection and chemical testing, clinical laboratory services, and technology solutions, among others. The company offers services to health insurance companies; pharmaceutical, biotechnology, medical device, and diagnostics companies and CROs; physicians, other healthcare providers; hospitals and health systems; governmental agencies; employers; patients and consumers; crop protection and chemical companies; academic institutions; independent clinical laboratories; and retailers; among others in the Americas, Europe, and Asia-Pacific. It operates manufacturing facilities in the US, Belgium, China, Japan, India, Germany, Singapore, the UK, and Switzerland. Labcorp is headquartered in Burlington, North Carolina, the US.
Labcorp Holdings Inc premium industry data and analytics
Products and Services
| Services | Brands |
|---|---|
| LabCorp | AccuDraw |
| Ambulatory Monitoring Services | LabCorp Link |
| Bone Marrow/HLA Services | Care Intelligence |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | New Products/Services | In June, the company launched ColoSense, the only RNA-based at-home test for colorectal cancer screening. |
| 2026 | Contracts/Agreements | In June, the company was chosen as Consumer Health Testing Partner of the Athletes Unlimited Softball League to advance women’s health, support athlete well-being, and drive fan engagement. |
| 2026 | Contracts/Agreements | In May, the company expanded its partnership with Epic to promote meaningful operational efficiencies, streamline lab ordering for clinicians and care teams, and improve access to diagnostic innovation for hospitals and health systems using Epic nationwide. |
Competitor Comparison
| Key Parameters | Labcorp Holdings Inc | Molina Healthcare Inc | Stryker Corp | Becton Dickinson and Co | Tenet Healthcare Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Burlington | Long Beach | Portage | Franklin Lakes | Dallas |
| State/Province | North Carolina | California | Michigan | New Jersey | Texas |
| No. of Employees | 71,000 | 19,000 | 56,000 | 72,000 | 77,000 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Adam H. Schechter | Chief Executive Officer; President; Chairman | Executive Board | 2020 | 61 |
| Julia A. Wang | Chief Financial Officer; Executive Vice President | Senior Management | 2024 | 55 |
| Amy B. Summy | Chief Marketing Officer; Executive Vice President | Senior Management | 2020 | 60 |
| Kathryn W. Kyle | Chief Legal Officer; Executive Vice President; Secretary | Senior Management | 2026 | 55 |
| Akinbolade Oyegunwa, PhD | Chief Information and Technology Officer; Executive Vice President | Senior Management | 2024 | 43 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer